-transparent.png){kind=logo}
Of 60 patients with rheumatoid arthritis treated with levamisole 35% showed a persistent decrease in neutrophil counts from pre-treatment levels and 6 (10%) develped severe neutropenia of less than 1.0 X 10(9)/1. One of these neutropenic patients recoverd without stopping therapy and the other 5 patients recovered rapidly when the drug was withdrawn. In some patients neutropenia recurred on reinstitution of levamisole.
Related Publications
G T Williams, and
S A Johnson, and
P A Dieppe, and
E C Huskisson
January 1980,
Agents and actions. Supplements,
G T Williams, and
S A Johnson, and
P A Dieppe, and
E C Huskisson
July 1982,
La Clinica terapeutica,
G T Williams, and
S A Johnson, and
P A Dieppe, and
E C Huskisson
June 1976,
Revue du rhumatisme et des maladies osteo-articulaires,
G T Williams, and
S A Johnson, and
P A Dieppe, and
E C Huskisson
January 1979,
Reumatologia,
G T Williams, and
S A Johnson, and
P A Dieppe, and
E C Huskisson
October 1977,
La Nouvelle presse medicale,
G T Williams, and
S A Johnson, and
P A Dieppe, and
E C Huskisson
January 1981,
Terapevticheskii arkhiv,
G T Williams, and
S A Johnson, and
P A Dieppe, and
E C Huskisson
March 1982,
Polskie Archiwum Medycyny Wewnetrznej,
G T Williams, and
S A Johnson, and
P A Dieppe, and
E C Huskisson
January 1977,
Arthritis and rheumatism,
G T Williams, and
S A Johnson, and
P A Dieppe, and
E C Huskisson
April 1982,
Bollettino della Societa italiana di biologia sperimentale,
G T Williams, and
S A Johnson, and
P A Dieppe, and
E C Huskisson
January 1978,
The Journal of rheumatology. Supplement,
